Cargando…
Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714180/ https://www.ncbi.nlm.nih.gov/pubmed/34971576 http://dx.doi.org/10.1016/S2352-3026(21)00378-1 |
| _version_ | 1784623865316507648 |
|---|---|
| author | Bennett, Charles L Gundabolu, Krishna Kwak, Larry W Djulbegovic, Benjamin Champigneulle, Oscar Josephson, Brian Martin, Linda Rosen, Steven T |
| author_facet | Bennett, Charles L Gundabolu, Krishna Kwak, Larry W Djulbegovic, Benjamin Champigneulle, Oscar Josephson, Brian Martin, Linda Rosen, Steven T |
| author_sort | Bennett, Charles L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8714180 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87141802021-12-29 Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events Bennett, Charles L Gundabolu, Krishna Kwak, Larry W Djulbegovic, Benjamin Champigneulle, Oscar Josephson, Brian Martin, Linda Rosen, Steven T Lancet Haematol In Focus Elsevier Ltd. 2022-01 2021-12-28 /pmc/articles/PMC8714180/ /pubmed/34971576 http://dx.doi.org/10.1016/S2352-3026(21)00378-1 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | In Focus Bennett, Charles L Gundabolu, Krishna Kwak, Larry W Djulbegovic, Benjamin Champigneulle, Oscar Josephson, Brian Martin, Linda Rosen, Steven T Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
| title | Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
| title_full | Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
| title_fullStr | Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
| title_full_unstemmed | Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
| title_short | Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events |
| title_sort | using twitter for the identification of covid-19 vaccine-associated haematological adverse events |
| topic | In Focus |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714180/ https://www.ncbi.nlm.nih.gov/pubmed/34971576 http://dx.doi.org/10.1016/S2352-3026(21)00378-1 |
| work_keys_str_mv | AT bennettcharlesl usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT gundabolukrishna usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT kwaklarryw usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT djulbegovicbenjamin usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT champigneulleoscar usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT josephsonbrian usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT martinlinda usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents AT rosenstevent usingtwitterfortheidentificationofcovid19vaccineassociatedhaematologicaladverseevents |